NCT05774015View on ClinicalTrials.gov

Effect of Oral Magnesium Supplementation on Type II Diabetes Mellitus Guided by Serum Ionized Magnesium Level

NACompletedINTERVENTIONAL
Enrollment

247

Participants

Timeline

Start Date

September 25, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

September 11, 2025

Conditions
Type 2 DiabetesMagnesium Disorder
Interventions
DIETARY_SUPPLEMENT

Magnesium Oxide tablet 500 mg

To supplement T2DM with Mg oxide tablets (500 mg total, 302 mg elemental) regardless on their magnesium level

Trial Locations (1)

Unknown

Mohammed AlZa'abi, Muscat

Sponsors

Collaborators (1)

Nova Biomedical
All Listed Sponsors
collaborator

Nova Biomedical

INDUSTRY

lead

Sultan Qaboos University

OTHER

NCT05774015 - Effect of Oral Magnesium Supplementation on Type II Diabetes Mellitus Guided by Serum Ionized Magnesium Level | Biotech Hunter | Biotech Hunter